TY  - GEN
AU  - Nicolini,Franck E
AU  - Chomel,Jean-Claude
AU  - Roy,Lydia
AU  - Legros,Laurence
AU  - Chabane,Kaddour
AU  - Ducastelle,Sophie
AU  - Nicolas-Virelizier,Emmanuelle
AU  - Michallet,Mauricette
AU  - Tigaud,Isabelle
AU  - Magaud,Jean-Pierre
AU  - Turhan,Ali
AU  - Guilhot,François
AU  - Hayette,Sandrine
TI  - The durable clearance of the T315I BCR-ABL mutated clone in chronic phase chronic myelogenous leukemia patients on omacetaxine allows tyrosine kinase inhibitor rechallenge
SN  - 2152-2669
PY  - 2011///0222
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents, Phytogenic
KW  - therapeutic use
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Fusion Proteins, bcr-abl
KW  - antagonists & inhibitors
KW  - Harringtonines
KW  - Homoharringtonine
KW  - Humans
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Protein Kinase Inhibitors
KW  - Protein-Tyrosine Kinases
KW  - Pyrimidines
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.3816/CLML.2010.n.073
ER  -